PCA Investment Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-900
Closed -$235K 54
2024
Q4
$235K Buy
900
+4
+0.4% +$1.19K 0.11% 124
2024
Q3
$289K Buy
896
+3
+0.3% +$981 0.14% 101
2024
Q2
$279K Buy
893
+1
+0.1% +$294 0.15% 101
2024
Q1
$254K Buy
892
+9
+1% +$2.63K 0.14% 103
2023
Q4
$254K Buy
883
+4
+0.5% +$1.09K 0.17% 92
2023
Q3
$236K Buy
879
+4
+0.5% +$998 0.17% 88
2023
Q2
$194K Buy
875
+4
+0.5% +$928 0.12% 119
2023
Q1
$211K Buy
+871
New +$214K 0.15% 107

Other funds holding AMGN

PCA Investment Advisory Services's AMGN Position: Q1 2025 in Review

PCA Investment Advisory Services sold out of Amgen (AMGN) in Q1 2025, closing a stake of 900 shares — an estimated $235K sold.

PCA Investment Advisory Services first reported a position in AMGN in Q1 2023 and held it in 8 quarters. The position peaked at $289K in Q3 2024. 2,927 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • PCA Investment Advisory Services reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • PCA Investment Advisory Services sold 900 Amgen shares in Q1 2025, an estimated $235K.
  • PCA Investment Advisory Services first reported a position in Amgen in Q1 2023 and held it in 8 quarters.
  • PCA Investment Advisory Services's Amgen position peaked at $289K in Q3 2024.
  • 2,927 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on PCA Investment Advisory Services's 13F filing for Q1 2025, filed 5 May 2025.